iTeos Therapeutics, Inc.

NASDAQ:ITOS

7.25 (USD) • At close April 30, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 000350-11.3030012.59553.90519.48741.716152.522240.504104.2710000000000
Kosten van de omzet 0000.3090.3030.2330.2240.19800.2260.2030.2020.180.16300.20.12600000000
Brutowinst 00034.691-0.303-11.536-0.224-0.19812.59553.67919.28441.514152.342240.341104.271-0.2-0.12600000000
Brutowinstmarge 0000.99101.0210010.9960.990.9950.9990.99910000000000
Onderzoek- en ontwikkelingskosten 28.71537.52336.68636.434.22527.77730.63829.18625.59825.42123.93226.9121.09617.38616.10214.23811.6439.2128.7266.1375.8255.964.9983.9024.351
Algemene en administratieve kosten 10.98211.80912.11212.45712.70312.36912.64213.43511.92711.10110.7611.47110.6159.5988.76115.1017.0465.7294.7992.3942.4182.2762.6992.0931.769
Verkoop- en marketingkosten 00000.00100000000000000000000
Verkoop-, algemene en administratieve kosten 10.98211.80912.11212.45712.70412.36912.64213.43511.92711.10110.7611.47110.6159.5988.76115.1017.0465.7294.7992.3942.4182.2762.6992.0931.769
Overige kosten 00002.0931.2130.7710.3260-1.381-0.698-0.439-0.7459.567-8.4840.060.24-0.2830.2650.0121.2230.945-0.232-0.5350.756
Bedrijfskosten 40.02149.33248.79848.85746.92937.24342.23241.43637.52535.14133.99437.94230.96626.02723.37426.51913.77414.6210.9537.2646.476.2896.665.1625.158
Bedrijfsresultaat -40.021-49.332-48.798-14.166-47.232-40.146-43.28-42.621-24.9317.383-15.2053.335120.811213.5279.408-29.339-18.689-14.941-13.525-8.531-8.243-8.236-7.697-5.995-6.12
Bedrijfsresultaat ratio 000-0.40503.55200-1.9790.322-0.780.080.7920.8880.7620000000000
Totaal overige inkomsten en kosten netto 6.50812.9755.6838.40610.42811.9589.8589.55310.5785.36313.2195.108-1.27810.524-6.9952.885.1550.0382.8371.2792.9962.8920.8050.2981.718
Inkomen voor belasting -33.513-36.357-43.115-5.76-36.804-28.188-33.422-33.068-14.35222.746-1.9868.443119.533224.04472.413-26.459-13.534-14.903-10.688-7.252-5.247-5.344-6.892-5.697-4.402
Inkomen voor belasting ratio 000-0.16502.49400-1.1390.422-0.1020.2020.7840.9320.6940000000000
Belastingkosten 0.6077.3552.2431.3681.4122.363-1.1811.2321.1992.293-2.9772.81749.95139.1722.771-0.11900.001-0.008-0.0500.0320.0290.0580
Nettowinst -34.613-43.712-45.358-7.128-38.216-30.551-32.241-34.3-15.55120.4530.9915.62669.582184.87269.642-26.459-13.534-14.904-10.68-7.202-5.247-5.376-6.921-5.755-4.402
Nettowinstmarge 000-0.20402.70300-1.2350.3790.0510.1350.4560.7690.6680000000000
WPA (Winst Per Aandeel) -0.8-1.08-1.05-0.18-1.07-0.85-0.9-0.96-0.440.570.0260.151.825.261.98-0.75-0.39-0.61-0.44-0.23-0.17-0.54-0.7-0.58-0.44
Verwaterde WPA -0.8-1.08-1.05-0.18-1.07-0.85-0.9-0.96-0.440.540.0260.151.824.891.86-0.75-0.39-0.61-0.44-0.23-0.17-0.54-0.7-0.58-0.44
EBITDA -33.682-47.777-47.693-12.441-47.232-30.336-43.28-42.621-23.6322.63-15.2058.353119.459224.49572.444-26.378-13.408-14.403-10.861-7.338-5.31-5.209-6.502-5.004-4.451
EBITDA ratio 000-0.35502.68400-1.8760.42-0.780.20.7830.9330.6950000000000